Citations

Clear

229 citation(s) found for "Chow, W".

Lessons learned from conducting the first cancer care delivery trial in the Alliance for Clinical Trials in Oncology (Alliance A191402CD)
Pacyna, Joel E. , Dueck, Amylou C. , Chang, George J. , Chow, Selina , Tilburt, Jon C. , Dueck, A. C. , Paskett, Electra D. , Kim, Simon

Mayo Clinic

Clinical Trials | April 13, 2023 | Volume: 20 | Issue: 5 | Pages: 559-563

10.1177/17407745231167123 | PMID 37050880 Get It

Introduction: Testing healthcare delivery interventions in rigorous clinical trials is a critical step in improving patient care, but conducting multisite randomized clinical trials to test the effect of care delivery interventions has unique challenges and requires foresight and planning. Methods: We conducted the first care delivery trial (A191402CD) in the Alliance for Clinical Trials in Oncology, a National Cancer Institute Community Oncology Research Program research base, which tested the effectiveness of two different decision aids for supporting shared decision-making about prostate cancer treatment. Our experience illustrates the kind of challenges that confront care delivery researchers as they seek to test interventions to improve the experiences of patients. Results: Lessons learned include the following: cluster-randomized designs introduce complexity; workflow disruption can discourage site participation; evidence-based methods may not always be sufficient. Conclusion: We conclude with the following recommendations: assessing feasibility requires special rigor; relationships and interpersonal dynamics must be leveraged. Our experiences may inform future care delivery research.
Mechanism of KMT5B haploinsufficiency in neurodevelopment in humans and mice
Sheppard, Sarah E. , Bryant, Laura , Wickramasekara, Rochelle N. , Vaccaro, Courtney, Robertson, Brynn, Hallgren, Jodi , Hulen, Jason, Watson, Cynthia J., Faùndes, Víctor , Duffourd, Yannis , Simon, M. Celeste , Cruz, Xavier de la , Padilla, Natàlia , Flores‐Méndez, Marco , Akizu, Naiara, Smiler, Jacqueline , Silva, Renata Pellegrino da, March, Michael , Diaz‐Rosado, Abdias , Barcelos, Isabella Peixoto de , Choa, Zhao Xiang, Dubourg, Christèle , Journel, Hubert, Démurger, Florence , Mulhern, Maureen , Akman, Cigdem I. , Lippa, Natalie , Baldridge, Dustin , Haeringen, Arie van , Snoeck-Streef, Irina, Chow, Penny , Hing, Anne , Graham, John M. , Faivre, Laurence , Shen, Wei , Mao, Rong , Palumbos, Janice C. , Viskochil, David , Gahl, William A. , Hauser, Natalie , Miller, Rebecca L. , Maffeo, Jessica, Afenjar, Alexandra , Doummar, Diane , Keren, Boris , Macklin‐Mantia, Sarah K. , Meerschaut, Ilse , Zweier, Christiane , Brewer, Carole, Saggar, Anand, Smeland, Marie Falkenberg , Kumar, Ajith , Elmslie, Frances , Deshpande, Charu, Nizon, Mathilde , Ierland, Yvette van , Wilke, Martina , Slegtenhorst, Marjon van, Koudijs, Suzanne M., Chen, Jin Yun, Dredge, David, Pier, Danielle B. , Wortmann, Saskia B. , Kamsteeg, Erik‐Jan , Koch, Johannes , Haynes, Devon , Pollack, Lynda, Titheradge, Hannah , Ranguin, Kara , Denommé‐Pichon, Anne‐Sophie , Weber, Sacha , Fuente, Rubén Pérez de la , Pozo, Jaime Sánchez del, Rosales, José Miguel Lezana , Joset, Pascal , Steindl, Katharina , Mei, Davide , Lespinasse, James, Philippe, Christophe , Dauriat, Benjamin, Raymond, Laure , Cueto‐González, Anna M. , Mignot, Cyril , Grotto, Sarah, Renaldo, Florence , Drivas, Theodore G. , Hennessy, Laura , Parenti, Ilaria , Kaiser, Frank J., Kuechler, Alma, Busk, Øyvind L. , Islam, Lily, Siedlik, Jacob A. , Henderson, Lindsay B. , Juusola, Jane, Person, Richard, Schnur, Rhonda E. , Vitobello, Antonio , Banka, Siddharth , Bhoj, Elizabeth , Stessman, Holly A.F. , Lee, Pearl , Simon, M Celeste , de la Cruz, Xavier , Padilla, Natália , Flores-Mendez, Marco , Akizu, Naiara , Smiler, Jacqueline , Li, Dong , March, Michael , Peixoto de Barcelos, Isabella , Choa, Zhao Xiang , Lim, Chin Yan , Dubourg, Christèle , Mulhern, Maureen , Lippa, Natalie , Andrews, Marisa , Baldridge, Dustin , Constantino, John , Chow, Penny , Faivre, Laurence , Shen, Wei , Palumbos, Janice , Gahl, William , Tifft, Cynthia , Macnamara, Ellen , Keren, Boris , Macklin, Sarah , Meerschaut, Ilse , Callewaert, Bert , Reis, André , Smeland, Marie F , Kumar, Ajith , Elmslie, Frances , Deshpande, Charu , van Ierland, Yvette , Wilke, Martina , Koudijs, Suzanne , Pier, Danielle , Wortmann, Saskia , Kamsteeg, Erik-Jan , Haynes, Devon , Titheradge, Hannah , Ranguin, Kara , Denommé-Pichon, Anne-Sophie , Weber, Sacha , Pérez de la Fuente, Rubén , Lezana Rosales, Jose Miguel , Steindl, Katharina , Rauch, Anita , Mei, Davide , Mari, Francesco , Guerrini, Renzo , Tran Mau-Them, Frederic , Moutton, Sébastien , Cueto-González, Anna M , Drivas, Theodore G , Parenti, Ilaria , Busk, Øyvind L , Siedlik, Jacob A , Vitobello, Antonio , Banka, Siddharth , Bhoj, Elizabeth J , Stessman, Holly A F , Sheppard, Sarah E; https://orcid.org/0000-0003-3480-8123, Bryant, Laura; https://orcid.org/0000-0001-8483-8940, Wickramasekara, Rochelle N; https://orcid.org/0000-0003-3090-9357, Lee, Pearl; https://orcid.org/0000-0002-1274-2891, Simon, M Celeste; https://orcid.org/0000-0001-9106-447X, Padilla, Natália; https://orcid.org/0000-0002-7872-2279, Akizu, Naiara; https://orcid.org/0000-0001-9222-6960, Li, Dong; https://orcid.org/0000-0002-2265-6727, March, Michael; https://orcid.org/0000-0001-9173-6862, Barcelos, Isabella Peixoto; https://orcid.org/0000-0002-3843-4520 de, Choa, Zhao Xiang; https://orcid.org/0000-0002-1838-7931, Lim, Chin Yan; https://orcid.org/0000-0002-1585-002X, Mulhern, Maureen; https://orcid.org/0000-0001-8642-4741, Joset, Pascal; https://orcid.org/0000-0002-4349-9951, Steindl, Katharina; https://orcid.org/0000-0002-4425-3072, Rauch, Anita , al, et

Mayo Clinic

Science Advances | April 10, 2023 | Volume: 9 | Issue: 10 | Pages: No page available

10.1126/sciadv.ade1463 | PMID 36897941 Get It

Pathogenic variants in KMT5B , a lysine methyltransferase, are associated with global developmental delay, macrocephaly, autism, and congenital anomalies (OMIM # 617788). Given the relatively recent discovery of this disorder, it has not been fully characterized. Deep phenotyping of the largest ( n = 43) patient cohort to date identified that hypotonia and congenital heart defects are prominent features that were previously not associated with this syndrome. Both missense variants and putative loss-of-function variants resulted in slow growth in patient-derived cell lines. KMT5B homozygous knockout mice were smaller in size than their wild-type littermates but did not have significantly smaller brains, suggesting relative macrocephaly, also noted as a prominent clinical feature. RNA sequencing of patient lymphoblasts and Kmt5b haploinsufficient mouse brains identified differentially expressed pathways associated with nervous system development and function including axon guidance signaling. Overall, we identified additional pathogenic variants and clinical features in KMT5B -related neurodevelopmental disorder and provide insights into the molecular mechanisms of the disorder using multiple model systems.
Angiotensin II for Vasodilatory Hypotension in Patients Requiring Mechanical Circulatory Support
Wieruszewski, Patrick M. , Seelhammer, Troy G. , Frazee, Erin N. , Busse, Laurence W. , Chow, Jonathan H. , Davison, Danielle , Gaglani, Bhavita , Lohuis, Caitlin C. ten, Mara, Kristin C. , Wittwer, Erica D. , Frazee, Erin N , Mara, Kristin C , Wieruszewski, Patrick M , Khanna, Ashish K. , Lohuis, Caitlin ten

Mayo Clinic

Journal of Intensive Care Medicine | December 16, 2022 | Volume: 38 | Issue: 5 | Pages: 464-471

10.1177/08850666221145864 | PMID 36524274 Get It

Background: Patients supported on mechanical circulatory support devices experience vasodilatory hypotension due to high surface area exposure to nonbiological and non-endothelialized surfaces. Angiotensin II has been studied in general settings of vasodilatory shock, however concerns exist regarding the use of this vasopressor in patients with pre-existing cardiac failure. The objective of this study was to assess the systemic and central hemodynamic effects of angiotensin II in patients with primary cardiac or respiratory failure requiring treatment with mechanical circulatory support devices. Methods: Multicenter retrospective observational study of adults supported on a mechanical circulatory support device who received angiotensin II for vasodilatory shock. The primary outcome was the intraindividual change from baseline in mean arterial pressure (MAP) and vasopressor dosage after angiotensin II. Results: Fifty patients were included with mechanical circulatory devices that were primarily used for cardiac failure (n = 41) or respiratory failure (n = 9). At angiotensin II initiation, the norepinephrine equivalent vasopressor dosage was 0.44 (0.34, 0.64) and 0.47 (0.33, 0.73) mcg/kg/min in the cardiac and respiratory groups, respectively. In the cardiac group, MAP increased from 60 to 70 mmHg (intraindividual P < .001) in the 1 h after angiotensin II initiation and the vasopressor dosage declined by 0.04 mcg/kg/min (intraindividual P < .001). By 12 h, the vasopressor dosage declined by 0.16 mcg/kg/min ( P = .001). There were no significant changes in cardiac index or mean pulmonary artery pressure throughout the 12 h following angiotensin II. In the respiratory group, similar but nonsignificant effects at 1 h on MAP (61-81 mmHg, P = .26) and vasopressor dosage (decline by 0.13 mcg/kg/min, P = .06) were observed. Conclusions: In patients requiring mechanical circulatory support for cardiac failure, angiotensin II produced beneficial systemic hemodynamic effects without negatively impacting cardiac function or pulmonary pressures. The systemic hemodynamic effects in those with respiratory failure were nonsignificant due to limited sample size.
Differential Flow of the Inspiratory Limb: A Pattern to Remember
Khosa, Sandeep , Taji, Jamil, Dosanjh, Grace, Chow, Andrew, Khosa, Sandeep

Mayo Clinic

Annals of the American Thoracic Society | December 1, 2022 | Volume: 19 | Issue: 12 | Pages: 2091-2096

10.1513/annalsats.202203-235cc | PMID 36454167 Get It

Thromboelastography Parameters do not Discriminate for Thrombotic Events in Hospitalized Patients With COVID-19
Kartiko, Susan , Yamane, David , Siddique, Abu Bakkar , Levine, Andrea R. , Jackson, Amanda, Wieruszewski, Patrick M. , Smischney, Nathan J. , Chow, Jonathan H. , Investigators, for the CRUSH COVID, Levine, Andrea R , Wieruszewski, Patrick M , Smischney, Nathan J , Chow, Jonathan H , Koizumi, Naoru , Sarani, Babak , Khanna, Ashish K. , Investigators, for the CRUSH COVID

Mayo Clinic

Journal of Intensive Care Medicine | November 30, 2022 | Volume: 38 | Issue: 5 | Pages: 449-456

10.1177/08850666221142265 | PMID 36448250 Get It

Background Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state; leading to multiple sequelae. We sought to detect whether thromboelastography (TEG) parameters would be able to detect thromboembolic events in patients hospitalized with COVID-19. Methods We performed a retrospective multicenter case–control study of the Collaborative Research to Understand the Sequelae of Harm in COVID (CRUSH COVID) registry of 8 tertiary care level hospitals in the United States (US). This registry contains adult patients with COVID-19 hospitalized between March 2020 and September 2020. Results A total of 277 hospitalized COVID-19 patients were analyzed to determine whether conventional coagulation TEG parameters were associated with venous thromboembolic (VTE) and thrombotic events during hospitalization. A clotting index (CI) >3 was present in 45.8% of the population, consistent with a hypercoagulable state. Eighty-three percent of the patients had clot lysis at 30 min (LY30) = 0, consistent with fibrinolysis shutdown, with a median of 0.1%. We did not find TEG parameters (LY30 area under the receiver operating characteristic [ROC] curve [AUC] = 0.55, 95% CI: 0.44-0.65, P value = .32; alpha angle [α] AUC = 0.58, 95% CI: 0.47-0.69, P value = .17; K time AUC = 0.58, 95% CI: 0.46-0.69, P value = .67; maximum amplitude (MA) AUC = 0.54, 95% CI: 0.44-0.64, P value = .47; reaction time [R time] AUC = 0.53, 95% CI: 0.42-0.65, P value = .70) to be a good discriminator for VTE. We also did not find TEG parameters (LY30 AUC = 0.51, 95% CI: 0.42-0.60, P value = .84; R time AUC = 0.57, 95%CI: 0.48-0.67, P value .07; α AUC = 0.59, 95%CI: 0.51-0.68, P value = .02; K time AUC = 0.62, 95% CI: 0.53-0.70, P value = .07; MA AUC = 0.65, 95% CI: 0.57-0.74, P value < .01) to be a good discriminator for thrombotic events. Conclusions In this retrospective multicenter cohort study, TEG in COVID-19 hospitalized patients may indicate a hypercoagulable state, however, its use in detecting VTE or thrombotic events is limited in this population.
A Comparison of Financial Hardship Among Survivors of Childhood Cancer Treated with and without Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study
Buchbinder, David , Wang, Huiqi , Huang, I‐Chan , Yabroff, K. Robin , Khera, Nandita , Yabroff, K Robin , Bhatt, Neel S. , Yasui, Yutaka , Armenian, Saro H. , Bhatia, Smita , Chow, Eric J. , Kirchhoff, Anne C. , Leisenring, Wendy M. , Armstrong, Gregory T. , Nathan, Paul C.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10981-10982

10.1182/blood-2022-159132 Get It

Increasing socioeconomically disadvantaged patients’ engagement in breast cancer surgery decision-making through a shared decision-making intervention (A231701CD): protocol for a cluster randomised clinical trial
Schumacher, Jessica R. , Zahrieh, David M. , Chow, Selina , Wills, Rachel, Hanlon, Bret M. , Tucholka, Jennifer L. , Neuman, Heather B. , Hanlon, Bret M , Neuman, Heather B , Taylor, John, Rathouz, Paul J.

Mayo Clinic

BMJ Open | November 17, 2022 | Volume: 12 | Issue: 11 | Pages: e063895

10.1136/bmjopen-2022-063895 | PMID 36396308 Get It

Introduction Socioeconomic disparities for breast cancer surgical care exist. Although the aetiology of the observed socioeconomic disparities is likely multifactorial, patient engagement during the surgical consult is critical. Shared decision-making may reduce health disparities by addressing barriers to patient engagement in decision-making that disproportionately impact socioeconomically disadvantaged patients. In this trial, we test the impact of a decision aid on increasing socioeconomically disadvantaged patients’ engagement in breast cancer surgery decision-making. Methods and analysis This multisite randomised trial is conducted through 10 surgical clinics within the National Cancer Institute Community Oncology Research Program (NCORP). We plan a stepped-wedge design with clinics randomised to the time of transition from usual care to the decision aid arm. Study participants are female patients, aged ≥18 years, with newly diagnosed stage 0–III breast cancer who are planning breast surgery. Data collection includes a baseline surgeon survey, baseline patient survey, audio-recording of the surgeon–patient consultation, a follow-up patient survey and medical record data review. Interviews and focus groups are conducted with a subset of patients, surgeons and clinic stakeholders. The effectiveness of the decision aid at increasing patient engagement (primary outcome) is evaluated using generalised linear mixed-effects models. The extent to which the effect of the decision aid intervention on patient engagement is mediated through the mitigation of barriers is tested in joint linear structural equation models. Qualitative interviews explore how barriers impact engagement, especially for socioeconomically disadvantaged women. Ethics and dissemination This protocol has been approved by the National Cancer Institute Central Institutional Review Board, and Certificate of Confidentiality has been obtained. We plan to disseminate the findings through journal publications and national meetings, including the NCORP network. Our findings will advance the science of medical decision-making with the potential to reduce socioeconomic health disparities. Trial registration number ClinicalTrials.gov Registry (NCT03766009).
From Neuroimaging to Computational Modeling of Burnout: The Traditional versus the Fuzzy Approach—A Review
Mikołajewska, Emilia , Prokopowicz, Piotr , Chow, YeeKong , Mikołajewski, Dariusz , Wallace, Brian, Eugene, Andy R., Chow, Yee Kong , Masiak, Jolanta , Wójcik, Grzegorz M. , Eugene, Andy R., Olajossy, Marcin

Mayo Clinic

Applied Sciences | November 14, 2022 | Volume: 12 | Issue: 22 | Pages: 11524

10.3390/app122211524 Get It

Occupational burnout, manifested by emotional exhaustion, lack of a sense of personal achievement, and depersonalization, is not a new phenomenon, but thusfar, there is no clear definition or diagnostic guidelines. The aim of this article wasto summarize all empirical studies to date that have used medical neuroimaging techniques to provide evidence or links regarding changes in brain function in occupational burnout syndrome from a neuroscientific perspective, and then use these to propose a fuzzy-based computational model of burnout.A comprehensive literature search was conducted in two major databases (PubMed and Medline Complete). The search period was 2006–2021, and searches were limited to the English language. Each article was carefully reviewed and appropriately selected on the basis of raw data, validity of methods used, clarity of results, and scales for measuring burnout. The results showed that the brain structures of patients with job burnout that are associated with emotion, motivation, and empathy weresignificantly different from healthy controls. These altered brain regions included the thalamus, hippocampus, amygdala, caudate, striatum, dorso-lateral prefrontal cortex, anterior cingulate cortex, posterior cingulate cortex, anterior insula, inferior frontal cingulate cortex, middle frontal cingulate cortex, temporoparietal junction, and grey matter. Deepening our understanding of how these brain structures are related to burnout will pave the way for better approaches fordiagnosis and intervention. As an alternative to the neuroimaging approach, the paper presents a late proposal of the PLUS (personal living usual satisfaction) parameter. It is based on a fuzzy model, wherein the data source is psychological factors—the same or similar to the neuroimaging approach. As the novel approach to searching for neural burnout mechanisms, we have shown that computational models, including those based on fuzzy logic and artificial neural networks, can play an important role in inferring and predicting burnout. Effective computational models of burnout are possible but need further development to ensure accuracy across different populations. There is also a need to identify mechanisms and clinical indicators of chronic fatigue syndrome, stress, burnout, and natural cognitive changes associated with, for example, ageing, in order to introduce more effective differential diagnosis and screening.
Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group
Finnes, Heidi D. , Child, Berrie, DeFrates, Sean, Kinsman, Katharine, Thorne, Andrew, Lockhorst, Robin, Urmanski, Angela, Amin, Sapna, Barr, Hallie, Baviskar, Sunanda, Beckman, Carrie , Chow, Nicholas , Derba, Megan, Erickson, Marsha K., Hennes, Emily R , Heisey, Heather D., Limvorasak, Suwicha , Luckritz, Todd, Mays, Theresa A., Nzelibe, Chukwuemeka N, Romanowski, Tracy, Smith, Camille M. , Tesoro, Debra, Toeniskoetter, Katelyn, Voytilla, Krista, Lentz, Sarah, Murphy, Jennifer, Lau, Rebecca

Mayo Clinic

American Journal of Health-System Pharmacy | October 6, 2022 | Volume: 80 | Issue: 1 | Pages: e67-e73

10.1093/ajhp/zxac267 | PMID 36200957 Get It

Surgical treatment of brain arteriovenous malformations: clinical outcomes of patients included in the registry of a pragmatic randomized trial
Darsaut, Tim E. , Magro, Elsa, Bojanowski, Michel W., Chaalala, Chiraz , Nico, Lorena , Bacchus, Emma, Klink, Ruby , Sabatier, Jean-François, Januel, Anne-Christine , Pélissou-Guyotat, I., Roche, Pièrre-Hugues , Brunel, Hervé, Proust, F. , Cornu, Philippe, Gaberel, Thomas , Barbier, Charlotte , Corre, Marine Le, Costalat, Vincent , Jecko, Vincent , Barreau, Xavier , Gauvrit, Jean‐Yves , Derrey, Stéphane , Papagiannaki, Chrysanthi , Abdalkader, Mohamad , Viard, Geraldine, Raymond, Jean , _, _, _, _, Chow, Michael M. C., Findlay, J. Max , Lesiuk, Howard , Drake, Brian , Santos, Marlene dos, Seizeur, Romuald, Pradier, Olivier, Ognard, Julien, Aouni, Mourad Cheddad El , Boursier, Romain, Thillays, F. , Roualdes, Vincent , Calvière, Lionel , Gauvrit, J.Y., Lecouillard, Isabelle, Nouhaud, Elodie, Raoult, Hélène , Eugene, François, Paya, Christophe, Ronzière, Thomas , Trystram, D. , Naggara, Olivier, Emery, Évelyne , Pellisou-Guyotat, Isabelle, Guyotat, Jacques, Berhouma, Monsef, Riva, Roberto, Biondi, Alessandra , Thines, L. , Bougaci, Nassim , Bracard, Serge, Anxionnat, René , Bernier‐Chastagner, Valérie , Civit, Thierry, Penchet, Guillaume, Gimbert, Edouard, Marnat, Gaulthier, Huchet, Aymeri, Herbreteau, Denis , Bibi, Richard, Ifergan, Héloïse , Janot, Kévin, Peyrière, Hadrien, Kaya, Jean-Marc, Touta, Adamou, Troude, Lucas, Boissonneau, Sébastien , Boch, Anne‐Laure , Clarençon, Frédéric , Nouet, Aurélien , Premat, Kévin, Gascou, Gregory, Lefevre, Pierre-Henri, Riquelme, Carlos , Cébula, H. , Ollivier, Irène , Pop, Raoul, Spatola, Giorgio, Chalumeau, Vanessa, Ikka, Léon , Ozanne, Augustin , Caroff, Jildaz, Chabert, Emmanuel , Rouchaud, Aymeric, Caire, François, Ricolfi, F. , Cao, Catherine, Mourier, Klaus-Luc, Thouant, Pierre, Farah, Walid, Carlson, Andrew P. , Silva, Luciana Alves Oliveira, Froio, Nayara de Lima, Mont’Alverne, Francisco J. A., Martins, Jose Luri, Mendes, George Nilton Nunes , Miranda, Rodrigo Rivera, Rouchaud, Aymeric , Rivera, Rodrigo , Ognard, Julien , Shotar, Eimad , Rouchaud, Aymeric , Ognard, Julien , Bojanowski, Michel W. , Iancu, Daniela , Weill, Alain , Roy, Daniel C. , Cognard, Christophe , Eker, Omer , Graillon, Thomas , Beaujeux, Rémy , Aldéa, Sorin , Piotin, Michel , Shotar, Eimad , Corre, Marine Le, Morandi, Xavier , Nguyen, Thanh N. , Tawk, Rabih G. , Huynh, Thien , Gévry, Guylaine , Gentric, Jean‐Christophe , _, _, _, _, Rempel, Jeremy L , O'Kelly, Cian J , Fahed, Robert , Santos, Marlene dos, Nonent, Michel , Timsit, Serge , Desal, Hubert , Blanc, Raphaël , Eugene, François, Bras, Anthony Le , Ferré, Jean‐Christophe , Paya, Christophe, Rodriguez-Régent, Christine , Kerleroux, Basile , Touzé, Emmanuel , Dumot, Chloé , Charbonnier, Guillaume , Gory, Benjamin , Boulouis, Grégoire , Velut, Stéphane , Bibi, Richard , Troude, Lucas , Sourour, Nader Antoine , Lenck, Stéphanie , Premat, Kévin , Corre, Marine Le, Bonafé, Alain , Dargazanli, Cyril , Gascou, Grégory , Lefèvre, Pierre-Henri , Pop, Raoul , Spelle, Laurent , Chalumeau, Vanessa , Gallas, Sophie , Mihalea, Cristian , Mounayer, Charbel , Thouant, Pierre , Silva, Gisele Sampaio , Montalverne, Francisco Jose

Mayo Clinic

Journal of Neurosurgery | September 9, 2022 | Volume: 138 | Issue: 4 | Pages: 891-899

10.3171/2022.7.jns22813 | PMID 36087316 Get It

OBJECTIVE The Treatment of Brain Arteriovenous Malformations Study (TOBAS) is a pragmatic study that includes 2 randomized trials and registries of treated or conservatively managed patients. The authors report the results of the surgical registry. METHODS TOBAS patients are managed according to an algorithm that combines clinical judgment and randomized allocation. For patients considered for curative treatment, clinicians selected from surgery, endovascular therapy, or radiation therapy as the primary curative method, and whether observation was a reasonable alternative. When surgery was selected and observation was deemed unreasonable, the patient was not included in the randomized controlled trial but placed in the surgical registry. The primary outcome of the trial was mRS score > 2 at 10 years (at last follow-up for the current report). Secondary outcomes include angiographic results, perioperative serious adverse events, and permanent treatment-related complications leading to mRS score > 2. RESULTS From June 2014 to May 2021, 1010 patients were recruited at 30 TOBAS centers. Surgery was selected for 229/512 patients (44%) considered for curative treatment; 77 (34%) were included in the surgery versus observation randomized trial and 152 (66%) were placed in the surgical registry. Surgical registry patients had 124/152 (82%) ruptured and 28/152 (18%) unruptured arteriovenous malformations (AVMs), with the majority categorized as low-grade Spetzler-Martin grade I–II AVM (118/152 [78%]). Thirteen patients were excluded, leaving 139 patients for analysis. Embolization was performed prior to surgery in 78/139 (56%) patients. Surgical angiographic cure was obtained in 123/139 all-grade (89%, 95% CI 82%–93%) and 105/110 low-grade (95%, 95% CI 90%–98%) AVM patients. At the mean follow-up of 18.1 months, 16 patients (12%, 95% CI 7%–18%) had reached the primary safety outcome of mRS score > 2, including 11/16 who had a baseline mRS score ≥ 3 due to previous AVM rupture. Serious adverse events occurred in 29 patients (21%, 95% CI 15%–28%). Permanent treatment-related complications leading to mRS score > 2 occurred in 6/139 patients (4%, 95% CI 2%–9%), 5 (83%) of whom had complications due to preoperative embolization. CONCLUSIONS The surgical treatment of brain AVMs in the TOBAS registry was curative in 88% of patients. The participation of more patients, surgeons, and centers in randomized trials is needed to definitively establish the role of surgery in the treatment of unruptured brain AVMs. Clinical trial registration no.: NCT02098252 (ClinicalTrials.gov)